Analystreport

Entasis Therapeutics Holdings (NASDAQ: ETTX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $19.00 price target on the stock.

Entasis Therapeutics Holdings Inc.  (ETTX) 
Last entasis therapeutics holdings inc. earnings: 11/14 07:30 am Check Earnings Report